 |
|
| News | |
|
The ARCS Board has moved to better define the membership categories, and Full Membership will be only available to those based in Australia and working primarily in or for the industry in therapeutic development roles. ARCS have established a new Class of membership called Overseas Associates to encourage membership from all the various countries with an interest in the Australian research environment and ARCS services. Their goal is to be able to meet the needs of this group more effectively in the future through e-learning and the development of co-operative agreements with organizations in their country. To this end ARCS have agreed to allow members of NZACRes to join ARCS at a discounted rate of $95 AUD. As a special Overseas Associate Member of ARCS,NZACRes members will be eligible for all member benefits (member-only areas of the website, information services, discounted attendance at ARCS events etc), including the DIA e-membership. The new ARCS Constitution will apply to applications and renewals and at renewal members will be asked to confirm their status and any change will only be implemented then. Click here to download the application form and apply today!
ANZMTG is an independent group was established in 1999 and strives:
ANZMTG membership is free and open to all researchers, industry representatives and consumers. The group is growing at a rapid pace and are about to publish their first newsletter (which will provide a good update of recent activities). The ANZMTG clinical trial portfolio currently includes 4 active studies and 3 proposed protocols. More study specific information is available on their website: www.anzmtg.org ANZMTG also encourages new research and is able to facilitate new protocol development. A study synopsis application form will be posted online soon. Application forms are available online and also attached please find a membership form.
The Clinical Trials & Research Providers Directory is a joint initiative by the Australia - New Zealand Biotechnology Alliance (ANZBA), Invest Australia and New Zealand Trade & Enterprise. Coordination and compilation of data is being managed by ANZBA. More information www.biotechalliance.org/clinicaltrials
How should high cost medicines be funded? Public consultation, December 2006 Towards a New Zealand Medicines Strategy Consultation Document - PHARMAC consultation document. ACART (Advisory Committee on Assisted Reproductive Technology) - Submissions on Human Gamete and Embryo Research. NEAC (National Ethics Advisory Committee)Ethical Guidelines for Observational Studies: Observation Research, Audits and Related Activities:
In June the NZACRes committee had the great opportunity to meet with members of the Multi-regional Ethics Committee (MEC) and the Northern X and Y committees in Auckland - to discuss some questions on the new multi-regional Ethics process and learn more about the committees` work. It was an open and constructive exchange and NZACRes could establish a channel of communication between the Ethics committee and members of the research community. The MEC made the following recommendations how researchers can assist the ethical review process:
Furthermore, some areas for training were identified and the NZACRes committee is looking at adequate training sources for researchers which can help to improve the quality of research applications. This will focus on two key aspects:
Following this meeting, a Safety Discussion Group formed to look at possible improvements of the safety reporting process. We were also informed that NEAC (the National Ethics Advisory Committee) is looking at the possibility of expedited review for low-risk observational studies; this is currently worked through by the ministry of Health. A review of the application forms will be carried out, and this will include the feasibility of electronic submissions
To facilitate timely review of amended documents by the MREC, the chair asks that the following should be considered by the applicant:
|
|
